Vapotherm, Inc. Stock

Equities

VAPO

US9221073052

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 03:21:18 2024-07-02 pm EDT 5-day change 1st Jan Change
2.11 USD -0.47% Intraday chart for Vapotherm, Inc. -0.94% +111.00%
Sales 2022 66.8M Sales 2023 68.67M Capitalization 6.14M
Net income 2022 -113M Net income 2023 -58M EV / Sales 2022 2.42 x
Net Debt 2022 89.45M Net Debt 2023 103M EV / Sales 2023 1.58 x
P/E ratio 2022
-0.64 x
P/E ratio 2023
-0.1 x
Employees 182
Yield 2022 *
-
Yield 2023
-
Free-Float 50.05%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.47%
1 week-0.94%
Current month-0.62%
1 month+178.73%
3 months+52.90%
6 months+122.11%
Current year+111.00%
More quotes
1 week
2.06
Extreme 2.06
2.14
1 month
0.70
Extreme 0.6999
2.23
Current year
0.70
Extreme 0.6999
2.23
1 year
0.70
Extreme 0.6999
4.10
3 years
0.70
Extreme 0.6999
254.96
5 years
0.70
Extreme 0.6999
435.36
10 years
0.70
Extreme 0.6999
435.36
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 12-06-25
Director of Finance/CFO 52 12-07-31
Chief Tech/Sci/R&D Officer 54 21-12-05
Members of the board TitleAgeSince
Director/Board Member 70 20-10-20
Chairman 74 10-04-30
Director/Board Member 64 17-09-30
More insiders
Date Price Change Volume
24-07-02 2.11 -0.47% 36,550
24-07-01 2.12 -0.15% 5,512
24-06-28 2.123 -0.79% 4,852
24-06-27 2.14 +1.90% 18,836
24-06-26 2.1 -1.41% 23,974

Delayed Quote OTC Markets, July 02, 2024 at 03:21 pm EDT

More quotes
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
More about the company